{
    "2020-11-20": [
        [
            {
                "time": "",
                "original_text": "天坛生物：创新引领药物研发 科研试验取得阶段性进展",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "创新",
                        "药物研发",
                        "科研试验",
                        "阶段性进展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：定增募集33亿 进一步增强核心竞争力",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "定增",
                        "募集",
                        "33亿",
                        "核心竞争力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}